Decentralized Clinical Trials Event Featuring Massive Bio Co-Founder 

Massive Bio Co-Founder and Chief Medical Officer Dr. Arturo Loaiza-Bonilla, MD, MSEd, was featured in Decentralized Clinical Trials: Accelerate Your Path to Proof of Concept with Increased Diversity, Accessibility, and Efficiency from Informa Connect. 

This event took place online virtually and in-person at the Hyatt Regency Coral Gables in Miami, Florida from June 6th to June 8th. Dr. Bonilla discussed the following topics in his presentation titled, “Using an AI-enabled Collaboration for Precision Oncology Decentralized Clinical Trials (DCT)”:
 

• Challenges and opportunities in oncology and precision medicine around clinical trials 
• Use of Artificial Intelligence (AI) and digital enabled technologies to implement a DCT strategy 
• Case study of Pharma-CRO-Virtual Site-Massive Bio in a global DCT oncology trial 
• Initiatives and Future perspectives 
• Q&A with the audience 

https://twitter.com/DrBonillaOnc/status/1523237426063462400

In addition to being a Co-Founder of Massive Bio, Dr. Bonilla is a renowned medical oncologist and has a distinguished clinical career in precision medicine oncology, immunotherapy, clinical trial design, digital health, and patient relations.  

To watch full presentations from Decentralized Clinical Trials: Accelerate Your Path to Proof of Concept with Increased Diversity, Accessibility, and Efficiency including Using an AI-enabled Collaboration for Precision Oncology Decentralized Clinical Trials (DCT), visit Informa Connect’s website or submit the form on this page.  

o is hosting. Fill out the form to watch our webinar to learn more about the causes, treatments, new therapies, and more on esophageal cancer!